Goto S, Kamada N, Delriviere L, Kobayashi E, Lord R, Ware F, Hara Y, Edwards-Smith C, Shimizu Y, Vari F
Department of Surgery, University of Queensland, Brisbane, Australia.
Microsurgery. 1995;16(3):167-70. doi: 10.1002/micr.1920160310.
A surgical experience with a method of rate orthotopic liver retransplantation (OLRT), and a preliminary study of immunological responses after OLRT are reported. OLRT was performed on the same recipient after the fist orthotopic liver transplantation (1st-OLT) according to our original (Kamada's) cuff method. Replacement of the portal vein (PV) and infra-hepatic vena cava (IHVC) cuffs was not technically difficult. However, there were no survivors from the first 6 retransplanted rats, mainly due to complications from defective supra-hepatic vena cava (SHVC) anastomoses. Unlike the human intra-abdominal SHVC, the posterior wall of the intra-abdominal SHVC in rats is too short and fragile to perform an end-to-end anastomosis twice between donor and recipient SHVC. For a second group of seven retransplants, a modification of the SHVC anastomosis was made between donor and recipient SHVC in conjunction with the recipient's cuff diaphragm. This enabled reanastomosis to be secure, resulting in the improved 1-week survival after isogenic OLRT (85.7%). This OLRT model has been applied to the fully allogeneic combination for several immunological studies and led to novel findings. Thus, an experimental model of a rat orthotopic liver retransplant model has the potential to allow more valuable insights into the immunological study of chronic rejection, sensitization and chimerism following liver retransplantation.
报告了一种速率原位肝再移植(OLRT)方法的手术经验以及OLRT后免疫反应的初步研究。根据我们最初的(Kamada氏)套袖法,在首次原位肝移植(第1次OLT)后对同一受体进行OLRT。门静脉(PV)和肝下腔静脉(IHVC)套袖的置换在技术上并不困难。然而,最初的6只再移植大鼠无一存活,主要是由于肝上腔静脉(SHVC)吻合口缺陷导致的并发症。与人类腹腔内SHVC不同,大鼠腹腔内SHVC的后壁太短且脆弱,无法在供体和受体SHVC之间进行两次端端吻合。对于第二组7次再移植,在供体和受体SHVC之间结合受体的套袖隔膜对SHVC吻合进行了改良。这使得再吻合更加安全,导致同基因OLRT后1周生存率提高(85.7%)。该OLRT模型已应用于完全异基因组合的多项免疫研究,并产生了新的发现。因此,大鼠原位肝再移植模型的实验模型有可能为肝再移植后慢性排斥反应、致敏和嵌合体的免疫研究提供更有价值的见解。